Kiniksa Pharmaceuticals International, plc
KNSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001730430
In the last 90 days, Kiniksa Pharmaceuticals International, plc insiders filed 0 open-market purchases and 2 sales; 267 institutions reported holding it in 13F filings for Q2 2026, worth $2.99B in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Kiniksa Pharmaceuticals International, plc as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 102
- −3 vs. Q1 2021
- Shares held
- 28.9M
- −190.6K (−0.7%) vs. Q1 2021
- Total value
- $402.0M
- −$135.7M (−25.2%) vs. Q1 2021
- New holders
- 14
- 38 more added
- Sold out
- 17
- 31 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KNSA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 267 | $2.99B |
| Q1 2026 | 228 | $2.18B |
| Q4 2025 | 224 | $1.77B |
| Q3 2025 | 204 | $1.59B |
| Q2 2025 | 189 | $1.10B |
| Q1 2025 | 176 | $889.4M |
| Q4 2024 | 160 | $773.1M |
| Q3 2024 | 176 | $991.2M |
| Q2 2024 | 133 | $659.4M |
| Q1 2024 | 154 | $768.1M |
| Q4 2023 | 142 | $600.4M |
| Q3 2023 | 134 | $605.8M |
| Q2 2023 | 127 | $447.7M |
| Q1 2023 | 132 | $339.6M |
| Q4 2022 | 125 | $450.0M |
| Q3 2022 | 104 | $383.2M |
| Q2 2022 | 92 | $290.5M |
| Q1 2022 | 96 | $306.0M |
| Q4 2021 | 103 | $346.4M |
| Q3 2021 | 101 | $332.0M |
| Q2 2021 | 102 | $402.0M |
| Q1 2021 | 105 | $537.6M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Kiniksa Pharmaceuticals International, plc; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 2,920,023 | $40.7M | 0.42% | 00.0% | Unchanged |
| Pictet Asset Management Ltd | 3,334,905 | $46.5M | 0.05% | +847,672+34.1% | Added |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −1,371,430−100.0% | Sold out |
| Avidity Partners Management LP | 0 | $0 | 0.00% | −1,330,700−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −219,800−100.0% | Sold out |
| Cormorant Asset Management, LP | 0 | $0 | 0.00% | −130,000−100.0% | Sold out |
| Parkman Healthcare Partners LLC | 0 | $0 | 0.00% | −80,603−100.0% | Sold out |
| California Public Employees Retirement System | 0 | $0 | 0.00% | −54,400−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −51,273−100.0% | Sold out |
| State of Wisconsin Investment Board | 0 | $0 | 0.00% | −49,700−100.0% | Sold out |
| Norges Bank | 0 | $0 | 0.00% | −21,947−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −21,360−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −12,140−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −7,548−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −5,694−100.0% | Sold out |
| Pacer Advisors, Inc. | 0 | $0 | 0.00% | −1,503−100.0% | Sold out |
| Abundance Wealth Counselors | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −985−100.0% | Sold out |
| Sowell Financial Services LLC | 0 | $0 | 0.00% | −226−100.0% | Sold out |